World Cancer Day – Joining efforts for a better cancer care

World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International Cancer Control (UICC) , the oldest and largest global membership organization dedicated to taking action on cancer. UICC has over 1150 member organizations in 172 countries and territories. Its mission is to reduce the global cancer burden, promote equity and awareness, ensuring that cancer control continues to be a priority in the world health and development agenda. 

More than half of oncologic patients receive radiation therapy as part of their treatment. Intelligent and comprehensive solutions offered by MVision AI actively support radiation oncology professionals to increase their productivity and improve their knowledge, in the best interest of cancer patients.

According to the World Health Organization, cancer is diagnosed in 18 million people every year, globally, and the numbers are expected to double by 2050. 

Extensive efforts are made to treat it in the best possible way and offer patients a chance to cure or extend their life for many years from diagnosis. Another important aim in oncology is to preserve and improve their quality of life, regardless of the stage of the disease.

Treating cancer implies joint actions of patients, their caregivers and health professionals. Unfortunately, access to adequate healthcare is not always available. Comprehensive treatments are available in 90% of the high-income countries but only 15% from low-income countries.  Closing the care gap is one of the main priorities of international societies and public health structures.

Substantial budget, but also a high level of education and intelligent solutions are needed to improve cancer care. Delivering quality radiation therapy in a timely manner is hampered by insufficient infrastructure or staff shortage. Implementing artificial intelligence in Radiation Oncology already demonstrated promising results for improving the complex process of treatment preparation and delivery.

MVision AI offers intelligent and comprehensive solutions for a fast, precise and standardized treatment. Improved efficiency allows professionals to better use their time, for example interacting more time with patients or improving their skills. It also is beneficial from the logistic perspective, enabling the clinics to treat a higher number of patients, if needed, and lowering the waiting times. Such upgrades are increasingly used in clinical practice, and probably will become part of the gold standard in the next future.

References

  1. World cancer day. https://www.worldcancerday.org/our-story
  2. UICC. https://www.uicc.org/who-we-are/about-uicc
  3. WHO. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer
  4. Worldwide cancer data. https://www.wcrf.org/cancer-trends/worldwide-cancer-data/#:~:text=Find%20information%20about%20world%20cancer,and%208.8%20million%20in%20women.
  5. Abdel-Wahab M, Gondhowiardjo SS, Rosa AA, et al. Global Radiotherapy: Current Status and Future Directions-White Paper. JCO Glob Oncol. 2021;7:827-842. doi:10.1200/GO.21.00029

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

1.5.2024

MVision AI receives TGA approval and market authorization for Australia

HELSINKI, Finland - May 1, 2024 An application for MVision AI Segmentation (Contour+) has been submitted and accepted by the Therapeutic Goods Administration (TGA) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation therapy treatment planning workflows. Contour+ accelerates the contouring process, provides guidance…

Press Releases

29.4.2024

Dharanipathy Rangaraj Appointed as CEO of MVision AI

Helsinki, Uusimaa - April 29, 2024 – MVision AI, a pioneering company in developing innovative AI solutions in the radiation oncology & imaging space, proudly announces the appointment of Dharanipathy Rangaraj as its new Chief Executive Officer (CEO). In his new capacity as CEO of MVision AI, Dharani will spearhead…

Press Releases

19.2.2024

MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON)

Finland, Helsinki, February 19, 2024 The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI's successful award of the tender from the Republic…

Press Releases